Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-028-4 | CAS number: 423-55-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30 August 1990 - 27 December 1990
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- Internal: In line with OECD 406. Two exposure groups (60% PFOB and neat PFOB) was used with 10 animals in each group . Two control groups with 4 animals each was used.
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The study was performed in 1990 before the LLNA method had been validated.
Test material
- Reference substance name:
- 1-bromoheptadecafluorooctane
- EC Number:
- 207-028-4
- EC Name:
- 1-bromoheptadecafluorooctane
- Cas Number:
- 423-55-2
- Molecular formula:
- C8BrF17
- IUPAC Name:
- 1-bromoheptadecafluorooctane
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- Neat PFOB: Physical state/Appearance: Clear colourless liquidImagent LN (60% w/V PFOB):Physical state/Appearance: White liquidStorage condition of test material: Room temperature
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Hra: (DH)SPF
- Sex:
- male/female
- Details on test animals and environmental conditions:
- Source: Hazleton Research Products, Inc.Age of animals at study initiation: Young adultWeight at study initiation: 350 to 550 gramsEnvironmental controls for the animal room was set to maintain a temperature of 72 deg F ± 6 deg F, a relative humidity of 50% ±20%, and a 12-hour light/12-hour dark cycle. Acclimation period: At least 7 days
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- Concentration/amount used for induction: interdermal treatment 100% PFOB and Imagent LN (60% w/v PFOB), amount 2 x 0,05 ml of each; topical 100% PFOBConcentration Freunds Complete Adjuvant (FCA): interdermal 50% test substance in FCA, amount 2 x 0,05 ml; and 50% FCA in sterile water, amount 2 x 0,05ml
- Day(s)/duration:
- 8 days
- Adequacy of induction:
- not specified
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 2 x 2 cm patch of undiluted PFOB
- Day(s)/duration:
- 24 hours
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Test group per dose:10 animals Control group per dose: 10 animalsNaive control: 4 animals
- Details on study design:
- The study was conducted using 10 test animals and four naive control animals per test material. The positive control group consisted of ten animals.Induction phaseOn Day 1, animals in each test group received duplicate 0.05-mL intradermal injections of a mixture of Freund's Complete Adjuvant in sterile water, the respective test material, and a mixture of the respective test material in Freund's Complete Adjuvant. For the positive control group, the animals received duplicate 0.05-mL intradermal injections of a mixture of Freund's Complete Adjuvant in sterile water, a 5% w/ v suspension of sulfathiazole in sterile water, and a 5% w/ v suspension of sulfathiazole in Freund's Complete Adjuvant. On Day 7, animals in all three test groups and the positive control group were pretreated with 10% w/w sodium lauryl sulfate in petrolatum applied topically at the shaved area of the Day 1 intradermal injections. On Day 8, the respective test or positive control received a topical application. The respective undiluted test material was applied to saturation to a 2-cm x 4-cm patch of Whatman No. 3 filter paper and placed over the injection sites. The positive control animals received an application of a 25% w/w suspension of sulfathiazole in petrolatum. The patches were occluded and remained in place for approximately 48 hours. The naive control animals were not treated during the induction phase. Two weeks after the topical induction dose, all animals received a challenge dose. The respective undiluted test material was applied to saturation to a 2-cm x 2-cm Whatman No. 3 filter paper. The patch was applied to one site on the shaved right flank of each animal in each respective test or naive control group. The positive control animals were treated with a 10% w/w suspension of sulfathiazole in petrolatum. The sites were examined for erythema and edema at 24 and 4B hours following application.Induction phaseOn Day 1, animals in each test group received duplicate 0.05-mL intradermal injections of a mixture of Freund's Complete Adjuvant in sterile water, the respective test material, and a mixture of the respective test material in Freund's Complete Adjuvant. For the positive control group, the animals received duplicate 0.05-mL intradermal injections of a mixture of Freund's Complete Adjuvant in sterile water, a 5% w/ v suspension of sulfathiazole in sterile water, and a 5% w/ v suspension of sulfathiazole in Freund's Complete Adjuvant. On Day 7, animals in all three test groups and the positive control group were pretreated with 10% w/w sodium lauryl sulfate in petrolatum applied topically at the shaved area of the Day 1 intradermal injections. On Day 8, the respective test or positive control received a topical application. The respective undiluted test material was applied to saturation to a 2-cm x 4-cm patch of Whatman No. 3 filter paper and placed over the injection sites. The positive control animals received an application of a 25% w/w suspension of sulfathiazole in petrolatum. The patches were occluded and remained in place for approximately 48 hours. The naive control animals were not treated during the induction phase. Two weeks after the topical induction dose, all animals received a challenge dose. The respective undiluted test material was applied to saturation to a 2-cm x 2-cm Whatman No. 3 filter paper. The patch was applied to one site on the shaved right flank of each animal in each respective test or naive control group. The positive control animals were treated with a 10% w/w suspension of sulfathiazole in petrolatum. The sites were examined for erythema and edema at 24 and 48 hours following application.
- Challenge controls:
- No
- Positive control substance(s):
- yes
- Remarks:
- Sulfathiazole
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: Naive control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 4
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: Naive control
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 4
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 60% w/v
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 60% w/v
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: Naive control
- Dose level:
- 60% w/v
- No. with + reactions:
- 0
- Total no. in group:
- 4
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: Naive control
- Dose level:
- 60% w/v
- No. with + reactions:
- 0
- Total no. in group:
- 4
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 100%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 100%
- No. with + reactions:
- 10
- Total no. in group:
- 10
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- No dermal reaction were observed in the test or naïve control animals treated with Imagent LN (60% PFOB) and sterilised neat PFOB. Dermal sensitisation responses were observed in animals treated with the positive control material.Imagent LN (60% PFOB) and sterilised neat PFOB were not a sensitiser in this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.